OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis
Neharika Jain, Haroon Kalam, Lakshyaveer Singh, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
Anna Allué‐Guardia, Juan Ignacio García, Jordi B. Torrelles
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 166

Advances in the antimicrobial treatment of osteomyelitis
Chao Zhong, Yueming Wu, Haodong Lin, et al.
Composites Part B Engineering (2022) Vol. 249, pp. 110428-110428
Closed Access | Times Cited: 48

Essential immune functions of fibroblasts in innate host defense
Kellen Cavagnero, Richard L. Gallo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44

Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis
Dipanwita Datta, Shaina Jamwal, Nishant Jyoti, et al.
FEBS Journal (2024) Vol. 291, Iss. 20, pp. 4433-4452
Open Access | Times Cited: 13

Ferroptotic MSCs protect mice against sepsis via promoting macrophage efferocytosis
Yuchen Pan, Jingman Li, Jiali Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 24

Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice
Natalia Yudintceva, Natalia Mikhailova, Viacheslav Fedorov, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 662-662
Open Access | Times Cited: 20

Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
Annu Devi, Isha Pahuja, Manisha Singh, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 6, pp. 600-612
Open Access | Times Cited: 12

Interactions Between Mesenchymal Stem Cells and Microorganisms: Unraveling the Paradox for Enhanced Mesenchymal Stem Cell-Based Therapy
Ensiyeh Kord-Parijaee, Elaheh Ferdosi-Shahandashti, Nasim Hafezi
Tissue Engineering Part B Reviews (2025)
Closed Access

Dual GSK-3β/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control Mycobacterium tuberculosis Infection
Sadaf Kalsum, Ruilan Xu, Mira Akber, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 550-550
Open Access

Review of the potential of mesenchymal stem cells for the treatment of infectious diseases
Amit Sharma, Anuja Chakraborty, Bithiah Grace Jaganathan
World Journal of Stem Cells (2021) Vol. 13, Iss. 6, pp. 568-593
Open Access | Times Cited: 26

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
Akanksha Verma, Antara Ghoshal, Ved Prakash Dwivedi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 17

Human mesenchymal stromal cells inhibitMycobacterium aviumreplication in clinically relevant models of lung infection
Timothy D. Shaw, Anna Krasnodembskaya, Gunnar N. Schroeder, et al.
Thorax (2024) Vol. 79, Iss. 8, pp. 778-787
Open Access | Times Cited: 3

3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy
Vishal Gupta, Vijaya V. Vaishnavi, Mario L. Arrieta‐Ortiz, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3

Heterogeneous Host–Pathogen Encounters Coordinate Antibiotic Resilience in Mycobacterium tuberculosis
Richa Mishra, Vikas Yadav, Madhura Guha, et al.
Trends in Microbiology (2020) Vol. 29, Iss. 7, pp. 606-620
Open Access | Times Cited: 19

Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities
Xueying Zhang, Qi Xie, Ziyu Ye, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15

A Living Material Constructed from Stem Cells for Tumor‐Tropic Oncotherapy with Real‐Time Imaging
Min Hao, He Xia, Jiazhi Duan, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 24
Closed Access | Times Cited: 11

Identification of host regulators of Mycobacterium tuberculosis phenotypes uncovers a role for the MMGT1-GPR156 lipid droplet axis in persistence
Haroon Kalam, Chih‐Hung Chou, Motohiko Kadoki, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 978-992.e5
Open Access | Times Cited: 6

Host-directed therapy against tuberculosis: Concept and recent developments
Sonakshi Udinia, Mrutyunjay Suar, Dhiraj Kumar
Journal of Biosciences (2023) Vol. 48, Iss. 4
Closed Access | Times Cited: 6

Emerging advances in identifying signal transmission molecules involved in the interaction between Mycobacterium tuberculosis and the host
Yue Wang, Qiyuan Shi, Qi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 9

Salmonella enhances osteogenic differentiation in adipose-derived mesenchymal stem cells
Nuradilla Mohamad‐Fauzi, Claire Shaw, Soraya Foutouhi, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top